5-HT.sub.1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5698571A · kind A · utility
24Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 1994 |
| Grant date | Dec 16, 1997 |
| Priority date | — |
| Expiry date | Oct 5, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for the treatment of migraine with compounds or compositions that are selective agonists of 5-HT.sub.1F receptors relative to other serotonin receptors that produce unwanted effects like vasoconstriction. The neurogenic meningeal extravasation that leads to the pain of migraine is inhibited.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.